Use of preoperative erythropoietin in head and neck surgery

Journal of Otolaryngology

Volumn 29, Issue 3, 2000, Pages 131-134

  Gall, Richard M ^a   Kerr, Paul D ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Erythropoietin; Head and neck cancer; Hemoglobin; Preoperative

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN;

ANEMIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HEAD AND NECK SURGERY; HEMOGLOBIN DETERMINATION; HUMAN; POSTOPERATIVE COMPLICATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL;

DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ERYTHROPOIETIN; HEAD AND NECK NEOPLASMS; HUMANS; INJECTIONS, SUBCUTANEOUS; PREOPERATIVE CARE; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0033943069     PISSN: 03816605     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Barra S, Barzan L, Maione A, et al. Blood transfusion and other prognostic variables in the survival of patients with cancer of the head and neck. Laryngoscope 1994; 104:95-98.
2. Eschbach JW, Egrie JC, Downing MR, et al. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N Engl J Med 1987; 316:73-78.
3. Fischl M, Galpin JE, Levine JD, et al. Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med 1990; 322:1488-1493.
4. Pincus T, Olsen NJ, Russell J, et al. Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis. Am J Med 1990; 89:161-168.
5. Bessho M, Jinnai I, Matsuda A, et al. Improvement of anemia by recombinant erythropoietin in patients with myelodysplastic syndromes and aplastic anemia. Int J Cell Cloning 1990; 8:445-458.
6. Goodnough LT, Rudnick S, Price TH, et al. Increased collection of autologous blood preoperatively with recombinant human erythropoietin therapy. N Engl J Med 1989; 321:1163-1167.
7. Mercuriali F, Zanella A, Barosi G, et al. Use of erythropoietin to increase the volume of autologous blood donated by orthopedic patients. Transfusion 1993; 33:55-60.
8. Braga M, Gianotti L, Vignali A, et al. Evaluation of recombinant human erythropoietin to facilitate autologous blood donation before surgery in anemic patients with cancer of the gastrointestinal tract. Br J Surg 1995; 82:1637-1640.
9. Canadian Orthopedic Perioperative Erythropoietin Study Group. Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement. Lancet 1993; 8855:1227-1232.
10. Faris PM, Ritter MA, Abels RI, The American Erythropoietin Study Group. The effect of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopaedic operation. J Bone Joint Surg 1996; 78A:62-72.
11. Means RT Jr, Krantz SB. Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 1992; 80:1639-1647.
12. Dunphy FR, Dunleavy TL, Harrison BR, et al. Erythropoietin reduces anemia and transfusions after paclitaxel and carboplatin. Cancer 1997; 79:1623-1628.
13. Gillis MC. Compendium of pharmaceuticals and specialties. 34th Ed. Toronto: Webcon, 1999.
14. Wake M, McCullough DE. Audit of blood transfusion policy in head and neck surgery. J Laryngol Otol 1990; 104:28-30.
15. Goldberg MA, McCutchen JW, Jove M, et al. A safety and efficacy comparison study of two dosing regimens of epoetin alfa in patients undergoing major orthopedic surgery. Am J Orthop 1996; 25:544-552.
16. Braga M, Gianotti L, Vignali A, et al. Erythropoiesis after therapy with recombinant human erythropoietin: a dose-response study in anemic cancer surgery patients. Vox Sang 1999; 76:38-42.